左甲状腺素随餐服用并增加15%剂量与空腹服用的随机对照试验
该随机对照试验纳入88例甲状腺功能控制良好的成人甲减患者,比较空腹与随早餐服用左甲状腺素(LT4)并增加15%剂量对TSH稳定性的影响。结果显示两组TSH稳定率相当(空腹组74.4% vs 早餐组73.3%,P无显著性差异),且早餐组自我报告幸福感改善更明显、更偏好非空腹服用。
要点
- 随早餐服用LT4并增加15%剂量可维持TSH稳定,与空腹服用相当。
- 早餐组患者自我报告幸福感改善更明显(33.3% vs 16.3%,P=.07)。
- 患者强烈偏好非空腹服用,研究结束时88.9%选择继续非空腹服用。
核心结论
- LT4随早餐服用并增加15%剂量可维持TSH稳定并改善患者幸福感。
- 鉴于患者强烈偏好,这种以患者为中心的方法可作为空腹服药的可行替代方案。
研究设计与样本
- 随机对照试验,纳入88例甲状腺功能控制良好的成人甲减患者。
- 随机分为空腹组(n=43)或随早餐服用并剂量调整组(n=45)。
- 每6周检测TSH、游离T4和总T3,必要时调整LT4剂量,随访至TSH稳定或最长24周。
- 空腹组在研究期后交叉至非空腹服用,进行类似随访。
主要发现
- TSH稳定率:空腹组74.4%(95%CI:61.0-88.0%),早餐组73.3%(95%CI:60.0-87.0%),组间比较P无显著性差异。
- 交叉组观察到类似结果。
- 早餐组自我报告幸福感改善更明显(33.3% vs 16.3%,P=.07)。
- 早餐组更偏好非空腹服用(76.2% vs 44.2%,P<.001)。
- 研究结束时88.9%的患者选择继续非空腹服用。
关键数值与推荐
- TSH稳定定义为连续2次值在参考范围内且较基线变化最大±1 mIU/L。
- 非空腹组LT4剂量增加15%。
临床怎么用
- 对于偏好随餐服药的甲减患者,可考虑随早餐服用LT4并增加15%剂量,但需监测TSH。
- 随餐服药可能提高患者幸福感和治疗偏好,但需个体化评估。
局限性
- 样本量较小(88例),随访时间最长24周。
- 自我报告幸福感改善的组间比较P=.07,未达到统计学显著性。
- 研究仅纳入甲状腺功能控制良好的成人患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Levothyroxine (LT4) is recommended for intake in a fasting state to optimize absorption. However, fasting intake is often burdensome and may reduce adherence. In a previous questionnaire study, we observed a strong patient preference for taking LT4 with breakfast. Therefore, we conducted a randomized controlled trial to evaluate whether nonfasting LT4 intake-accompanied by a 15% dose increase-could maintain TSH stability compared to fasting LT4 intake. METHODS: Adults with well-controlled hypothyroidism were randomized to fasting or dose-adjusted, breakfast LT4 intake. TSH, free T4, and total T3 were measured every 6 weeks, followed by LT4 dose adjustment if needed. The primary outcome was TSH stability, defined as 2 consecutive values within the reference range and a maximum ±1 mIU/L change from baseline. Patients were followed until TSH stability was reached, with a maximum of 24 weeks. After the initial study period, patients in the fasting group were invited to cross over to nonfasting intake, with similar follow-up. RESULTS: Eighty-eight patients (80.7% female, median age 62y [interquartile range: 49-69]) were randomized to fasting (n = 43) or breakfast intake (n = 45). TSH stability was comparable between groups: 74.4% [95% confidence interval (CI): 61.0-88.0%] in the fasting vs 73.3% (95%CI: 60.0-87.0%) in the breakfast group (P = not significant). Similar findings were observed in the crossover group. The breakfast group reported greater improvement in self-reported well-being (33.3% vs 16.3%, P = .07) and a stronger preference for nonfasting intake (76.2% vs 44.2%, P < .001). By the end of the study, 88.9% chose to continue nonfasting intake. CONCLUSION: LT4 ingestion with breakfast with a 15% dose increase maintained TSH stability and improved patient well-being. Given the strong patient preference, this patient-centered approach may offer a viable alternative to fasting administration.
引用
- Willems JIA, van Twist DJL, Helmich F, et al. Fasting vs Nonfasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial. J Clin Endocrinol Metab. 2026. PMID: 41431302. doi:10.1210/clinem/dgaf686
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。